This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Bringing you the latest updates on pharma competition law, patent litigation, regulatory frameworks, compliance and licensing agreements.

State of the Industry — Critical Bio/Pharma Policy Updates for Compliance After COVID | Covington

Share this article

Stefanie Doebler, Partner at Covington & Burling LLP, kicked off the Pharmaceutical Compliance Congress (PCC) Hybrid Event in September 2021, with a State of the Industry Spotlight Session focused on critical bio/pharma policy updates for compliance after COVID. The session assessed the current state of bio/pharmaceutical companies post-pandemic, evaluated current healthcare policies and rebate rules impacting the industry, and helped navigate drug pricing transparency and reporting on a state and federal level. Watch the full presentation recording below.


Share this article

Upcoming event

European Pharma Law Academy

17 - 21 Jan 2022, Cambridge University
European Pharma Law Academy
Go to site